-
Sulfaphenazole: A Decision Framework for CYP2C9
2026-08-31
Sulfaphenazole is more than a CYP2C9 inhibitor: it is a useful bridge between enzyme selectivity, antimycobacterial screening, and vascular biology. This evidence-based guide explains how to choose assays, interpret concentrations, and avoid overextending translational conclusions.
-
Lanabecestat (AZD3293) in Reliable Cell Assays
2026-08-31
This scenario-driven guide explains how Lanabecestat (AZD3293), SKU BA8438, can be integrated into cell-based Alzheimer’s disease research while separating BACE1 pathway effects from nonspecific assay artifacts. It connects product specifications with published evidence on amyloid-beta reduction, synaptic transmission, dosing, and practical vendor selection.
-
PPARγ Activation in DSS-Induced IBD
2026-08-30
The reference study identifies PPARγ activation as a regulator of macrophage polarization in dextran sulfate sodium-induced inflammatory bowel disease, linking reduced STAT-1 signaling and enhanced STAT-6 signaling to improved intestinal inflammation and barrier integrity. Its combined cell and mouse experiments provide a mechanistic framework for evaluating PPARγ agonists in inflammatory process modulation while highlighting important limits of acute, preclinical models.
-
Polymyxin B: Designing Cleaner Immune Assays
2026-08-29
Polymyxin B sulfate is more than a membrane-active antibiotic in Gram-negative infection research. This guide explains how to separate direct bactericidal effects from dendritic-cell, inflammatory, and microbiome-related readouts when designing translational assays.
-
Vincristine Sulfate: Cancer Research Workflow
2026-08-28
Build more reproducible vincristine experiments by linking microtubule dynamics to dose–response design, orthogonal phenotyping, and recovery testing. This workflow distinguishes biochemical potency from cell-specific response and shows how to troubleshoot solubility, timing, and assay variability.
-
Dimetridazole Targets P. aeruginosa Quorum Sensing
2026-08-28
Yuan et al. show that Dimetridazole and Ribavirin can suppress Pseudomonas aeruginosa virulence-associated traits by perturbing quorum sensing regulation rather than acting solely as conventional growth inhibitors. The study connects phenotypic assays, transcriptomics, antibiotic-combination testing, and in vivo infection models to support an antivirulence research framework.
-
Niclosamide Workflows for Cancer Research
2026-08-27
Build more informative STAT3-centered cancer assays with Niclosamide by separating pathway suppression, proliferative arrest, and cell death. This workflow pairs mechanistic biomarkers with time-resolved viability measurements for prostate cancer and acute myelogenous leukemia model applications.
-
Metronidazole Workflows for OAT3 and Microbiome Studies
2026-08-27
Metronidazole is a versatile research probe for OAT3-mediated transport, drug-drug interaction modulation, and anaerobic microbiome experiments. This practical guide connects transporter assays with allergic-rhinitis microbiota workflows while clearly separating established evidence from protocol recommendations.
-
Captopril Workflows for ACE Inhibition Research
2026-08-26
Captopril supports a versatile workflow that spans quantitative ACE inhibition in hypertension research, bradykinin-linked intestinal physiology, and exploratory apoptosis induction in cancer cells. This guide translates its biochemical profile into practical assay design, cross-domain controls, solution-handling safeguards, and troubleshooting decisions.
-
Hexetidine (NSC-17764) Assay Workflows
2026-08-26
Build more informative oral antimicrobial studies with Hexetidine (NSC-17764), from strain-specific MIC testing to matrix-aware biofilm experiments. This workflow emphasizes solvent controls, saliva and protein effects, time-course endpoints, and copper-ion combination testing rather than relying on MIC alone.
-
Diphenyleneiodonium chloride in Redox Assays
2026-08-25
Diphenyleneiodonium chloride, or DPI, enables parallel interrogation of redox enzymes and GPR3-linked cAMP signaling. This guide translates a recent citrus canker resistance study into practical ROS, iron, viability, and pathway-control workflows while emphasizing DPI’s selectivity limits and troubleshooting requirements.
-
Leucovorin Calcium in Gastric Assembloids
2026-08-25
Leucovorin Calcium adds a controlled folate-rescue arm to patient-derived gastric assembloid experiments, helping separate tumor-intrinsic methotrexate sensitivity from stromal protection. This workflow combines matched organoids, stromal subpopulations, viability testing, and rescue-index analysis for more informative antifolate drug resistance research.
-
Doxycycline as a Mechanistic Probe in Cancer Models
2026-08-24
Doxycycline is more than a tetracycline antibiotic: it can help dissect metalloproteinase inhibition, matrix remodeling, and antiproliferative activity in cancer research. This guide shows how to distinguish direct compound effects from delivery-system, antimicrobial, and assay-specific confounders.
-
SAR405: A Precision Vps34 Inhibitor Workflow
2026-08-24
SAR405 enables selective interrogation of Vps34-dependent PI3P production, autophagy, vesicle trafficking, and lysosome biology without directly suppressing class I or II PI3Ks. This workflow also translates a newly recognized nuclear PI3P–mismatch repair connection into practical assays for cancer research and genome-maintenance studies.
-
Carrier-Platin and Rapid ROS-Driven Cancer Cell Death
2026-08-23
Liu et al. report carrier-platin, a platinum nanotherapeutic that confines ultrasmall platinum particles within a poly(amino acids) carrier to generate a rapid intracellular ROS burst. The resulting cancer-cell death occurs within about 30 minutes, is distinct from conventional apoptosis and ferroptosis, and shows preclinical activity against multidrug-resistant tumors with limited systemic toxicity.